Results 121 to 130 of about 32,411 (258)

Coronary Flow Reserve [PDF]

European Heart Journal, 1996
openaire   +1 more source

Using Q‐methodology and the 3P model of learning to evaluate medicine and dentistry students' experiences with a blended anatomy laboratory design

Anatomical Sciences Education, EarlyView.
Abstract In response to the COVID‐19 pandemic, the Faculty of Medicine and Health Sciences at McGill University initiated blended curriculum delivery for first‐year medicine and dentistry students in anatomy, combining limited hands‐on dissection with online laboratory‐adjacent activities using a 3D software application.
Jobanpreet Dhillon, Mayssa Moukarzel, George Laggis, Geoffroy Noël, Nicole M. Ventura, Sean C. McWatt   +5 more
wiley   +1 more source

Autism Screening in the First Year and Beyond: Comparison of Multiple Measures

Autism Research, EarlyView.
ABSTRACT Autism screening aids in early detection and diagnosis. Several screeners are available for toddlers 16 months and older, but there is little data on the accuracy of screening measures used in the first year of life. A community sample (N = 1641) completed three screeners—M‐CHAT‐R, ITC, VIRSA—online at 6, 9, 12, 18, and 24 months of age ...
Devon N. Gangi, Chandni Parikh, Monique Moore Hill, Shyeena Maqbool, Rachel Ni, Simon Dvorak, Gregory S. Young, Sally Ozonoff   +7 more
wiley   +1 more source

Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?

Vascular Health and Risk Management, 2015
Tim P van de Hoef,1 Martijn Meuwissen,2 Jan J Piek1 1AMC Heartcentre, Academic Medical Center, University of Amsterdam, Amsterdam, 2Amphia Hospital, Breda, the Netherlands Abstract: Fractional flow reserve (FFR) is a well-validated clinical coronary ...
van de Hoef TP, Meuwissen M, Piek JJ
doaj  

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Publisher Correction: Genome-wide association study of coronary flow reserve assessed by cardiac perfusion PET suggests a role for NF-κB pathway. [PDF]

Nat Cardiovasc Res
Venkatesh R, Cherlin T, Wayne N, Kumar R, Guare L, Singamneni VP, Irving B, Dudek S, Penn Medicine BioBank, Levin MG, Setia-Verma S, Guerraty MA.   +11 more
europepmc   +1 more source

The importance of time-to-event analysis in measuring the prognostic impact of coronary flow reserve. [PDF]

Eur Heart J, 2022
Kelshiker MA, Seligman H, Howard JP, Petraco R.   +3 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Associations of AI-derived coronary CT angiography features with CZT-SPECT coronary flow reserve and FFR-CT. [PDF]

Front Cardiovasc Med
Ni J, Pang Z, Guo H, Chaudhary AK, Zhao F, Chen Y, Wang J, Li J.   +7 more
europepmc   +1 more source

Prognostic Impact of Coronary Flow Reserve in Patients With Reduced Left Ventricular Ejection Fraction. [PDF]

J Am Heart Assoc, 2022
Joh HS, Shin D, Lee JM, Lee SH, Hong D, Choi KH, Hwang D, Boerhout CKM, de Waard GA, Jung JH, Mejia-Renteria H, Hoshino M, Echavarria-Pinto M, Meuwissen M, Matsuo H, Madera-Cambero M, Eftekhari A, Effat MA, Murai T, Marques K, Doh JH, Christiansen EH, Banerjee R, Kim HK, Nam CW, Niccoli G, Nakayama M, Tanaka N, Shin ES, Chamuleau SAJ, van Royen N, Knaapen P, Koo BK, Kakuta T, Escaned J, Piek JJ, van de Hoef TP, ILIAS Registry Investigators [Link].   +37 more
europepmc   +1 more source